AVTR Stock Overview
Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Avantor, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$20.14 |
| 52 Week High | US$28.00 |
| 52 Week Low | US$19.59 |
| Beta | 1.35 |
| 11 Month Change | -17.76% |
| 3 Month Change | -19.50% |
| 1 Year Change | 0.25% |
| 33 Year Change | -49.17% |
| 5 Year Change | 17.85% |
| Change since IPO | 38.90% |
Recent News & Updates
Are Investors Undervaluing Avantor, Inc. (NYSE:AVTR) By 28%?
Nov 16
Avantor (NYSE:AVTR) Takes On Some Risk With Its Use Of Debt
Oct 26Avantor: Uninspiring, Even Amidst Some Green Shoots
Oct 24Recent updates
Are Investors Undervaluing Avantor, Inc. (NYSE:AVTR) By 28%?
Nov 16Avantor (NYSE:AVTR) Takes On Some Risk With Its Use Of Debt
Oct 26Avantor: Uninspiring, Even Amidst Some Green Shoots
Oct 24Why We're Not Concerned About Avantor, Inc.'s (NYSE:AVTR) Share Price
Sep 02Avantor, Inc. (NYSE:AVTR) Shares Could Be 35% Below Their Intrinsic Value Estimate
Aug 15Avantor: Yet To Evidence Economic Value For Valuation Repricing, Reiterate Hold
Aug 13At US$20.82, Is Avantor, Inc. (NYSE:AVTR) Worth Looking At Closely?
Jul 16We Think Avantor (NYSE:AVTR) Is Taking Some Risk With Its Debt
May 22Are Investors Undervaluing Avantor, Inc. (NYSE:AVTR) By 32%?
Apr 26Avantor, Inc.'s (NYSE:AVTR) Popularity With Investors Is Clear
Apr 04We Think You Can Look Beyond Avantor's (NYSE:AVTR) Lackluster Earnings
Feb 21Is Avantor (NYSE:AVTR) A Risky Investment?
Feb 11Should You Think About Buying Avantor, Inc. (NYSE:AVTR) Now?
Jan 21Getting In Cheap On Avantor, Inc. (NYSE:AVTR) Might Be Difficult
Dec 31Are Investors Undervaluing Avantor, Inc. (NYSE:AVTR) By 23%?
Dec 09Avantor: Contracting Growth And Returns On Equity At 37x Earnings - Enemies To The Value Investor
Dec 01These 4 Measures Indicate That Avantor (NYSE:AVTR) Is Using Debt Extensively
Oct 24Is Now An Opportune Moment To Examine Avantor, Inc. (NYSE:AVTR)?
Oct 03Is There An Opportunity With Avantor, Inc.'s (NYSE:AVTR) 32% Undervaluation?
Sep 10Avantor: Customers Destocking, Order Volumes Down, Challenges To Rating (Rating Downgrade)
Sep 08Avantor (NYSE:AVTR) Has A Pretty Healthy Balance Sheet
Jul 10Avantor: Promising Long-Term Buy With Potential For Opportunistic Entry
Jun 28At US$19.71, Is Avantor, Inc. (NYSE:AVTR) Worth Looking At Closely?
Jun 22A Look At The Fair Value Of Avantor, Inc. (NYSE:AVTR)
Jun 04Do Avantor's (NYSE:AVTR) Earnings Warrant Your Attention?
Apr 17Is Avantor (NYSE:AVTR) A Risky Investment?
Apr 04Why Avantor, Inc. (NYSE:AVTR) Could Be Worth Watching
Mar 22Avantor Non-GAAP EPS of $0.32 beats by $0.02, revenue of $1.8B beats by $10M
Feb 03Does This Valuation Of Avantor, Inc. (NYSE:AVTR) Imply Investors Are Overpaying?
Feb 02Avantor: Re-Rating To Buy, Paying Fair Price At 17x Forward P/E (Rating Upgrade)
Jan 28With EPS Growth And More, Avantor (NYSE:AVTR) Makes An Interesting Case
Jan 09Here's Why Avantor (NYSE:AVTR) Can Manage Its Debt Responsibly
Dec 27Is It Time To Consider Buying Avantor, Inc. (NYSE:AVTR)?
Dec 14Avantor: Reduce To Hold, Awaiting Convergence Of Price, Fundamentals
Nov 10Avantor Non-GAAP EPS of $0.34 beats by $0.01, revenue of $1.86B beats by $10M
Oct 28Estimating The Intrinsic Value Of Avantor, Inc. (NYSE:AVTR)
Oct 27Avantor raised to Buy at Citi on valuation disconnect
Oct 05Do Avantor's (NYSE:AVTR) Earnings Warrant Your Attention?
Oct 03We Think Avantor (NYSE:AVTR) Can Stay On Top Of Its Debt
Sep 21Is Avantor, Inc. (NYSE:AVTR) Potentially Undervalued?
Sep 09Avantor Non-GAAP EPS of $0.37 misses by $0.01, revenue of $1.91B misses by $70M
Jul 28Estimating The Intrinsic Value Of Avantor, Inc. (NYSE:AVTR)
Jul 18Shareholder Returns
| AVTR | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | -6.7% | -5.8% | -1.0% |
| 1Y | 0.2% | 1.7% | 30.3% |
Return vs Industry: AVTR matched the US Life Sciences industry which returned 1.2% over the past year.
Return vs Market: AVTR underperformed the US Market which returned 30.4% over the past year.
Price Volatility
| AVTR volatility | |
|---|---|
| AVTR Average Weekly Movement | 3.3% |
| Life Sciences Industry Average Movement | 8.8% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: AVTR has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: AVTR's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1904 | 14,500 | Michael Stubblefield | www.avantorsciences.com |
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies.
Avantor, Inc. Fundamentals Summary
| AVTR fundamental statistics | |
|---|---|
| Market cap | US$13.42b |
| Earnings (TTM) | US$309.60m |
| Revenue (TTM) | US$6.82b |
44.3x
P/E Ratio2.0x
P/S RatioIs AVTR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AVTR income statement (TTM) | |
|---|---|
| Revenue | US$6.82b |
| Cost of Revenue | US$4.53b |
| Gross Profit | US$2.29b |
| Other Expenses | US$1.98b |
| Earnings | US$309.60m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.45 |
| Gross Margin | 33.53% |
| Net Profit Margin | 4.54% |
| Debt/Equity Ratio | 88.3% |
How did AVTR perform over the long term?
See historical performance and comparison